Cistor 1 mg Injection should be administered by a healthcare professional. For intravenous administration, inject slowly over at least 15 minutes into a vein. For intramuscular administration, inject deep into a large muscle mass (e.g., gluteal muscle). Do not administer intrathecally or epidurally.

Cistor acts by inhibiting cyclooxygenase (COX) enzymes, primarily COX-2, leading to reduced prostaglandin synthesis. This results in decreased pain perception, inflammation, and fever.

• •Hypersensitivity to Cistor or any excipients
• •Active gastrointestinal bleeding or peptic ulcer disease
• •Severe renal or hepatic impairment
• •History of asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs
• •Coagulation disorders or patients on anticoagulant therapy (increased bleeding risk)

Store below 30°C. Protect from light. Do not freeze. Keep out of reach of children.

Symptoms of overdose may include severe nausea, vomiting, abdominal pain, lethargy, drowsiness, blurred vision, dizziness, and in severe cases, renal failure or respiratory depression. Management is primarily supportive; maintain airway, monitor vital signs, and provide symptomatic treatment. Hemodialysis is unlikely to be effective.

Pregnancy Category C. Use in pregnancy is not recommended, especially during the third trimester, due to potential adverse effects on fetal cardiovascular system and inhibition of labor. Small amounts may pass into breast milk; use with caution in lactating mothers after consulting a doctor and weighing benefits against risks.